Albert J Wong

Title: Albert J Wong: Innovator in Tumor Treatment

Introduction

Albert J Wong is a prominent inventor based in Menlo Park, CA (US). He has made significant contributions to the field of medical science, particularly in the development of peptide vaccines for tumor treatment. With a total of 8 patents to his name, Wong's work has the potential to impact cancer therapies significantly.

Latest Patents

Wong's latest patents include innovative approaches to combat tumors. One notable patent is for peptide vaccines based on the EGFRvIII sequence. These vaccines are designed to induce immune responses against EGFRvIII, which is crucial for treating tumors associated with this specific mutation. The patent also outlines methods for inhibiting the formation or growth of EGFRvIII tumors, as well as methods for immunizing and treating subjects affected by these tumors. Another significant patent involves a growth factor-sensitive vesicle that bears growth factor receptors. This invention focuses on methods for treating growth factor-overexpressing neoplasms, showcasing Wong's commitment to advancing cancer treatment.

Career Highlights

Throughout his career, Wong has worked with esteemed institutions, including Leland Stanford Junior University. His research and innovations have garnered attention in the scientific community, contributing to advancements in cancer treatment methodologies.

Collaborations

Wong has collaborated with various professionals in his field, including Emily Piccione Griffin. These partnerships have facilitated the exchange of ideas and fostered innovation in his research endeavors.

Conclusion

Albert J Wong's contributions to the field of tumor treatment through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in cancer therapies, making a significant impact on the medical community.